Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies

P Soblechero‐Martín, A López‐Martínez… - Neuropathology and …, 2021 - Wiley Online Library
Utrophin is an autosomal paralogue of dystrophin, a protein whose deficit causes Duchenne
and Becker muscular dystrophies (DMD/BMD). Utrophin is naturally overexpressed at the …

Targeting angiogenesis in Duchenne muscular dystrophy

P Podkalicka, O Mucha, J Dulak, A Loboda - Cellular and Molecular Life …, 2019 - Springer
Duchenne muscular dystrophy (DMD) represents one of the most devastating types of
muscular dystrophies which affect boys already at early childhood. Despite the fact that the …

AAV‐Mediated nuclear localized PGC1α4 delivery in muscle ameliorates sarcopenia and aging‐associated metabolic dysfunctions

M Guo, J Zhang, Y Ma, Z Zhu, H Zuo, J Yao, X Wu… - Aging …, 2023 - Wiley Online Library
Sarcopenia is characterized of muscle mass loss and functional decline in elder individuals
which severely affects human physical activity, metabolic homeostasis, and life quality …

circINSR promotes proliferation and reduces apoptosis of embryonic myoblasts by sponging miR-34a

X Shen, X Zhang, W Ru, Y Huang, X Lan, C Lei… - … Therapy-Nucleic Acids, 2020 - cell.com
As a diverse and abundant class of endogenous RNAs, circular RNAs (circRNAs) participate
in processes including cell proliferation and apoptosis. Nevertheless, few researchers have …

Anti-inflammatory and general glucocorticoid physiology in skeletal muscles affected by Duchenne muscular dystrophy: Exploration of steroid-sparing agents

S Herbelet, A Rodenbach, B De Paepe… - International Journal of …, 2020 - mdpi.com
In Duchenne muscular dystrophy (DMD), the activation of proinflammatory and metabolic
cellular pathways in skeletal muscle cells is an inherent characteristic. Synthetic …

MicroRNAs in dystrophinopathy

A Lee, J Moon, J Yu, C Kho - International Journal of Molecular Sciences, 2022 - mdpi.com
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD), which
represent the range of dystrophinopathies, account for nearly 80% of muscle dystrophy …

High-throughput identification of post-transcriptional utrophin up-regulators for Duchenne muscle dystrophy (DMD) therapy

E Loro, K Sengupta, S Bogdanovich, K Whig… - Scientific Reports, 2020 - nature.com
Upregulation of endogenous utrophin offers great promise for treating DMD, as it can
functionally compensate for the lack of dystrophin caused by DMD gene mutations, without …

MiRNAs and muscle regeneration: Therapeutic targets in Duchenne muscular dystrophy

AE Aránega, E Lozano-Velasco… - International journal of …, 2021 - mdpi.com
microRNAs (miRNAs) are small non-coding RNAs required for the post-transcriptional
control of gene expression. MicroRNAs play a critical role in modulating muscle …

Longitudinal study of three microRNAs in Duchenne muscular dystrophy and Becker muscular dystrophy

S Trifunov, D Natera-de Benito… - Frontiers in …, 2020 - frontiersin.org
Our objective was to investigate the potential of three microRNAs, miR-181a-5p, miR-30c-
5p, and miR-206 as prognostic biomarkers for long-term follow up of Duchenne muscular …

Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives

R Brusa, F Magri, N Bresolin, GP Comi… - Cellular and Molecular Life …, 2020 - Springer
Noncoding RNAs (ncRNAs), such as miRNAs and long noncoding RNAs, are key regulators
of gene expression at the post-transcriptional level and represent promising therapeutic …